Drug intelligence / Profile preview

microporous polyglycan styptic powder

Development stage
Unknown
Lead developer
Dalian Bomei Pharmaceutical
Administration
Topical
01

Overview

Microporous polyglycan styptic powder, also referred to as compound microporous polychitosan styptic powder, is a topical hemostatic agent composed of chitosan-based microporous particles. It functions as a molecular sieve that rapidly absorbs the fluid component of blood upon contact with a wound, thereby concentrating platelets, red blood cells, and essential clotting proteins such as thrombin and fibrinogen at the site of injury. This process accelerates the natural coagulation cascade and creates a physical matrix that effectively seals damaged blood vessels. The agent is primarily investigated for its efficacy in managing capillary, venous, and arteriolar bleeding during surgical procedures, specifically to prevent post-operative bleeding following endoscopic submucosal dissection (ESD) of rectal lesions.

Brand names
Bomei
Other names
compound microporous polychitosan styptic powdermicroporous polychitosan styptic powderCMPCP

Beyond the preview

Go deeper on microporous polyglycan styptic powder.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on microporous polyglycan styptic powder.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call